Adjuvant chemotherapy with anthracyclines. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Lymph Nodes Cell Line, Tumor Axilla Tumor Cells, Cultured Neoplastic Cells, Circulating

Organisms1

Diseases70

Breast Neoplasms Neoplasm Recurrence, Local Lymphatic Metastasis Lung Neoplasms Colonic Neoplasms Neoplasm Metastasis Adenocarcinoma Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Stomach Neoplasms Neoplasms Sarcoma Rectal Neoplasms Osteosarcoma Heart Diseases Neutropenia Testicular Neoplasms Recurrence Leukemia P388 Amenorrhea Ovarian Neoplasms Bone Neoplasms Carcinoma Disease Progression Soft Tissue Neoplasms Neoplasms, Germ Cell and Embryonal Brain Neoplasms Nasopharyngeal Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Pancreatic Neoplasms Urinary Bladder Neoplasms Liver Neoplasms Vomiting Neoplasm Invasiveness Neoplasms, Second Primary Germinoma Carcinoma, Ductal, Breast Lethargy Carcinoma, Transitional Cell Leukopenia Nausea Carcinoma, Lobular Peritoneal Neoplasms Leukemia, Myeloid, Acute Carcinoma, Squamous Cell Muscle Neoplasms Fatigue Leukemia Dysgerminoma Medulloblastoma Leukemia L1210 Retroperitoneal Neoplasms Cerebellar Neoplasms Alopecia Mucositis Neoplasms, Hormone-Dependent Head and Neck Neoplasms Neoplastic Cells, Circulating Carcinosarcoma Menopause, Premature Lymphoma, Non-Hodgkin Hodgkin Disease Adenocarcinoma, Mucinous Retinal Neoplasms Carcinoma, Pancreatic Ductal Pulmonary Blastoma Pregnancy Complications, Neoplastic Esophageal Neoplasms Urologic Neoplasms Leiomyosarcoma

Chemicals and Drugs85

Anthracyclines Antibiotics, Antineoplastic Naphthacenes Doxorubicin Cyclophosphamide Daunorubicin Fluorouracil Antineoplastic Agents Adjuvants, Immunologic Epirubicin Cisplatin Methotrexate Aclarubicin Taxoids Paclitaxel Antimetabolites, Antineoplastic Vinblastine Tegafur Adjuvants, Pharmaceutic Freund's Adjuvant Levamisole Bridged Compounds Idarubicin Carubicin Receptor, erbB-2 Deoxycytidine Etoposide Tamoxifen Carboplatin Tumor Markers, Biological Receptors, Estrogen Antineoplastic Agents, Phytogenic Antineoplastic Agents, Alkylating Organoplatinum Compounds Mitomycin Razoxane Leucovorin Lomustine Antineoplastic Agents, Hormonal DNA Topoisomerases, Type II Mitoxantrone Uracil Vincristine Nogalamycin Oxonic Acid Receptors, Progesterone Antibodies, Monoclonal, Humanized Ifosfamide Semustine Thiotepa Bleomycin Cytarabine P-Glycoprotein Aconitic Acid Granulocyte Colony-Stimulating Factor Antibodies, Monoclonal Platinum Compounds Dacarbazine Antigens, Neoplasm Anthraquinones Thymidylate Synthase Vindesine Floxuridine Melphalan Camptothecin Dexrazoxane Carmustine Cardiotoxins Ki-67 Antigen Lentinan Topoisomerase II Inhibitors Drug Combinations Liposomes Mitomycins Goserelin Aluminum Hydroxide Fluoxymesterone Antidotes DNA, Neoplasm Verapamil Carbazilquinone Keratin-19 Endonucleases Asparaginase DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Disease-Free Survival Neoplasm Staging Treatment Outcome Radiotherapy, Adjuvant Survival Analysis Prognosis Survival Rate Drug Administration Schedule Neoadjuvant Therapy Follow-Up Studies Mastectomy Kaplan-Meier Estimate Randomized Controlled Trials as Topic Clinical Trials as Topic Retrospective Studies Multivariate Analysis Prospective Studies Proportional Hazards Models Cystectomy Gastrectomy Radiotherapy Pneumonectomy Salvage Therapy Infusions, Intravenous Lymph Node Excision Risk Factors Antineoplastic Protocols Predictive Value of Tests Clinical Trials, Phase III as Topic Chemoradiotherapy Chemoradiotherapy, Adjuvant Radiotherapy Dosage Risk Assessment Mastectomy, Radical Actuarial Analysis Immunohistochemistry Mastectomy, Segmental SEER Program Mastectomy, Modified Radical Induction Chemotherapy Feasibility Studies Cohort Studies Administration, Oral Patient Selection Drug Therapy Postoperative Care Digestive System Surgical Procedures Random Allocation Cranial Irradiation Multicenter Studies as Topic Palliative Care Chemotherapy, Cancer, Regional Perfusion Orchiectomy Drug Screening Assays, Antitumor Remission Induction Meta-Analysis as Topic Tomography, X-Ray Computed Observation Probability Pilot Projects Transplantation, Autologous Mastectomy, Simple Colectomy Fatal Outcome Hematopoietic Stem Cell Transplantation Neoplasm Grading Treatment Failure Odds Ratio Immunotherapy Analysis of Variance Esophagectomy

Psychiatry and Psychology1

Phenomena and Processes14

Drug Resistance, Neoplasm Time Factors Dose-Response Relationship, Drug Premenopause Drug Resistance, Multiple Menopause Gene Expression Regulation, Neoplastic Drug Resistance Genes, erbB-2 Apoptosis Probability Cell Survival Menopause, Premature Odds Ratio

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science3

Survival Rate SEER Program Fatal Outcome

Named Groups1

Health Care35

Disease-Free Survival Treatment Outcome Survival Analysis Survival Rate Follow-Up Studies Kaplan-Meier Estimate Randomized Controlled Trials as Topic Clinical Trials as Topic Retrospective Studies Multivariate Analysis Prospective Studies Proportional Hazards Models Risk Factors Antineoplastic Protocols Predictive Value of Tests Clinical Trials, Phase III as Topic Age Factors Risk Assessment Actuarial Analysis SEER Program Feasibility Studies Cohort Studies Patient Selection Postoperative Care Random Allocation Multicenter Studies as Topic Palliative Care Meta-Analysis as Topic Probability Pilot Projects Cancer Care Facilities Fatal Outcome Treatment Failure Odds Ratio Analysis of Variance

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care

Chemotherapy, Adjuvant Anthracyclines Antineoplastic Combined Chemotherapy Protocols Antibiotics, Antineoplastic Naphthacenes Doxorubicin Breast Neoplasms Combined Modality Therapy Cyclophosphamide Daunorubicin Disease-Free Survival Neoplasm Staging Fluorouracil Antineoplastic Agents Treatment Outcome Adjuvants, Immunologic Epirubicin Cisplatin Radiotherapy, Adjuvant Survival Analysis Prognosis Methotrexate Neoplasm Recurrence, Local Survival Rate Aclarubicin Drug Administration Schedule Neoadjuvant Therapy Taxoids Lymphatic Metastasis Paclitaxel Antimetabolites, Antineoplastic Vinblastine Tegafur Lung Neoplasms Follow-Up Studies Adjuvants, Pharmaceutic Freund's Adjuvant Levamisole Bridged Compounds Idarubicin Colonic Neoplasms Neoplasm Metastasis Carubicin Receptor, erbB-2 Adenocarcinoma Mastectomy Kaplan-Meier Estimate Deoxycytidine Etoposide Randomized Controlled Trials as Topic Drug Resistance, Neoplasm Time Factors Tamoxifen Clinical Trials as Topic Carboplatin Retrospective Studies Tumor Markers, Biological Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Receptors, Estrogen Multivariate Analysis Antineoplastic Agents, Phytogenic Antineoplastic Agents, Alkylating Stomach Neoplasms Prospective Studies Proportional Hazards Models Organoplatinum Compounds Mitomycin Razoxane Leucovorin Lomustine Antineoplastic Agents, Hormonal Neoplasms Cystectomy Gastrectomy DNA Topoisomerases, Type II Sarcoma Radiotherapy Mitoxantrone Uracil Pneumonectomy Dose-Response Relationship, Drug Salvage Therapy Premenopause Vincristine Rectal Neoplasms Osteosarcoma Nogalamycin Heart Diseases Oxonic Acid Infusions, Intravenous Neutropenia Receptors, Progesterone Testicular Neoplasms Recurrence Lymph Node Excision Antibodies, Monoclonal, Humanized Ifosfamide Risk Factors Drug Resistance, Multiple

No FAQ available that match "adjuvant chemotherapy with anthracyclines"